Latest Breaking News On - Maria palasis - Page 7 : vimarsana.com

Published: Feb 17, 2021   Thought leader in the ENT treatment community brings insight from clinical practice to next stage of development for LYR-210 and pipeline   WATERTOWN, Mass. (BUSINESS WIRE) Lyra Therapeutics, Inc. (Nasdaq: LYRA), a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose and throat (ENT) diseases, today announced that Robert Kern, MD has been named Chief Medical Officer. He will also remain in his current position as the George A. Sisson Professor and Chair, Department of Otolaryngology – Head and Neck Surgery, Northwestern University Feinberg School of Medicine. Dr. Kern is the immediate past president of the

United statesGeorgea sissonRobert kernMaria palasisWayne state universityInternational society of inflammationJefferson medical college of thomas universityNational institutes of healthNorthwestern university feinberg school of medicineGeorgetown universityDepartment of otolaryngologyLyra therapeutics incAmerican rhinologic societyChief medicalNeck surgeryNorthwestern university feinberg school